What Isomorphic announced on 17 November
Isomorphic Labs, the London-based drug-design company run by Demis Hassabis and owned mainly by Alphabet, announced a $5bn Series C on Tuesday 17 November 2026, about EUR 4.4bn at recent rates. The round was co-led by Greenoaks and Sequoia Capital. The company said it was oversubscribed and did not disclose a valuation. Bloomberg reported earlier this month that it would be about $50bn.
| Round | $5bn Series C |
|---|---|
| Co-leads | Greenoaks and Sequoia Capital |
| New investors | Andreessen Horowitz and others |
| Returning investors | Alphabet, Thrive Capital, MGX, GV, CapitalG, Temasek, UK Sovereign AI Fund |
| Previous round | $2.1bn Series B, May 2026 |
| Valuation | Not disclosed, Bloomberg reported about $50bn |
On our arithmetic, $5bn is about 2.4 times the $2.1bn raised six months earlier. Sources: Sifted and The Next Web, which cites Bloomberg.
The price rests on scaling, not on a trial
In January Hassabis said the first clinical trials were expected by the end of 2026, and he gave Bloomberg no updated target this time, saying more would be announced in 2027. No regulator has yet approved an AI-designed drug. Isomorphic reports more than 20 programmes and partnerships with Eli Lilly, Novartis and Johnson & Johnson, and positive preclinical results from its design engine.
Sequoia's Konstantine Buhler said the firm backed Isomorphic because it has found scaling laws for its models, meaning performance improves with more compute and data. On our reading that makes access to chips the central risk, which is why Hassabis stressed "very secure compute pipelines" and Google designs its own AI chips.
What to check before you buy from a vendor like this
If your company licenses AI-designed molecules, buys discovery software or co-invests with a platform like this, ask for the written trial timeline, the named compute suppliers and what happens to your agreement if the vendor's valuation falls. A round this size buys time and talent. It does not shorten a regulatory timetable, and you should not budget as if it does.
Read next: Sequoia Shuts London and Backs Europe From California | Ten Banks Financed a Company That Had Launched Eight Days Earlier



